You just read:

ARMO BioSciences Presents Efficacy Data from its Phase 1b Trial in Patients with Metastatic Renal Cell Carcinoma at ESMO Immuno-Oncology Congress 2017

News provided by

ARMO BioSciences, Inc.

Dec 08, 2017, 01:30 EST